Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hypochlorite mouthwash versus normal saline for early reduction of oral viral load in hospitalized COVID-19 patients
IRCT20120215009014N398Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium hypochlorite and Normal Saline-Benha University in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Oral viral load. Started Jul 2021; status: completed.
02
Drugs
sodium hypochloriteNormal Saline-Benha University
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120215009014N398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N398.